Christiansen; Lise Brown

Patent Applications and Registrations

Patent applications and USPTO patent grants for Christiansen; Lise Brown.The latest application filed is for "urea glucokinase activators".

Company Profile

0.17.21

Christiansen; Lise Brown - Lyngby N/A DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Urea glucokinase activators Grant 8,362,049 - Murray , et al. January 29, 2	2013-01-29
Urea glucokinase activators Grant 8,318,778 - Murray , et al. November 27, 2	2012-11-27
Urea Glucokinase Activators App 20120165375 - Murray; Anthony ; et al.	2012-06-28
2-(2-hydroxyphenyl) benzothiadiazines useful for treating obesity and diabetes Grant 8,022,066 - Petersen , et al. September 20, 2	2011-09-20
Haloalkylsulfone substituted compounds useful for treating obesity and diabetes Grant 7,939,690 - Petersen , et al. May 10, 2	2011-05-10
2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes Grant 7,915,299 - Petersen , et al. March 29, 2	2011-03-29
2- ( 2 -hydroxyphenyl) -quinazolin-4-ones Useful For Treating Obesity And Diabetes App 20100249161 - Petersen; Anders Klarskov ; et al.	2010-09-30
Haloalkylsulfone Substituted Compounds Useful For Treating Obesity And Diabetes App 20100113536 - Petersen; Anders Klarskov ; et al.	2010-05-06
Novel Salicylic Anilides App 20100075932 - Olesen; Preben ; et al.	2010-03-25
NOVEL 2-(2-HYDROXYPHENYL)BENZIMlDAZOLES USEFUL FOR TREATING OBESITY AND DIABETES App 20100063122 - Peterson; Anders Klarskov ; et al.	2010-03-11
Haloalkylsulfone Substituted Compounds Useful For Treating Obesity And Diabetes App 20100041657 - Olesen; Preben Houlberg ; et al.	2010-02-18
Salicylic anilides Grant 7,645,791 - Olesen , et al. January 12, 2	2010-01-12
Novel 2-(2-hydroxyphenyl) Benzothiadiazines Useful For Treating Obesity And Diabetes App 20090325941 - Petersen; Anders Klarskov ; et al.	2009-12-31
Novel Haloalkoxy-Substituted Salicylic Anilides App 20090062396 - Olesen; Preben Houlberg ; et al.	2009-03-05
Novel Salicylic Anilides App 20090005434 - Olesen; Preben Houlberg ; et al.	2009-01-01
Sulfonamide Derivatives App 20080255240 - Christiansen; Lise Brown ; et al.	2008-10-16
Novel Trifluoromethoxy-Substituted Aryl Anilides App 20080234381 - Olesen; Preben Houlberg ; et al.	2008-09-25
Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV Grant 7,235,538 - Kanstrup , et al. June 26, 2	2007-06-26
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV Grant 7,192,952 - Kanstrup , et al. March 20, 2	2007-03-20
Indole derivatives for use as chemical uncoupler App 20070010559 - Christiansen; Lise Brown ; et al.	2007-01-11
Novel salicylic anilides App 20070004794 - Olesen; Preben ; et al.	2007-01-04
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV App 20050148606 - Kanstrup, Anders Bendtz ; et al.	2005-07-07
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV Grant 6,869,947 - Kanstrup , et al. March 22, 2	2005-03-22
Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV App 20040034014 - Kanstrup, Anders Bendtz ; et al.	2004-02-19
Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV Grant 6,645,995 - Kanstrup , et al. November 11, 2	2003-11-11
Hetrocyclic compounds that are inhibitors of the enzyme DPP-IV App 20030199528 - Kanstrup, Anders B. ; et al.	2003-10-23
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV App 20030105077 - Kanstrup, Anders Bendtz ; et al.	2003-06-05
Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV App 20020161001 - Kanstrup, Anders Bendtz ; et al.	2002-10-31
Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV App 20020103384 - Kanstrup, Anders ; et al.	2002-08-01
Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV Grant 6,380,398 - Kanstrup , et al. April 30, 2	2002-04-30
cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes Grant 6,316,494 - Jacobsen , et al. November 13, 2	2001-11-13
New therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV App 20010031780 - Kanstrup, Anders ; et al.	2001-10-18
Novel Cis-3,4-chroman Derivatives Useful In The Prevention Or Treatment Of Estrogen Related Diseases Or Syndromes App 20010021710 - JACOBSEN, POUL ; et al.	2001-09-13
cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes Grant 6,043,269 - Jacobsen , et al. March 28, 2	2000-03-28
(+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes Grant 5,985,306 - Jacobsen , et al. November 16, 1	1999-11-16
Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes Grant 5,958,967 - Jacobsen , et al. September 28, 1	1999-09-28
Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes Grant 5,919,817 - Jacobsen , et al. July 6, 1	1999-07-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.